In a cohort of 100 ovarian cancer patients, ROR1 was shown to be increased and statistically correlated with FIGO stage, tumour grade and lymph node metastasis [18]. This evidence concerns the gene ROR1 and metastatic malignant neoplasm in the lymph nodes.